Strasbourg, France, January 7, 2008 - Faust Pharmaceuticals S.A., a clinical-stage product company specializing in the discovery and development of
drugs for diseases of the nervous system, announced that it has entered into a research agreement with Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company.
Under the agreement, Faust will apply its NEUROCLID(TM) platform to identify novel drug candidates that target undisclosed G Protein-Coupled Receptors (GPCRs) of interest to Takeda...
Faust Pharmaceuticals' Press Release-
